ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Bicycle Therapeutics PLC

Bicycle Therapeutics PLC (BCYC)

20.21
0.63
(3.22%)
Closed July 06 4:00PM
20.14
-0.07
(-0.35%)
After Hours: 7:59PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
20.21
Bid
20.01
Ask
20.74
Volume
225,723
19.27 Day's Range 20.5399
0.00 52 Week Range 0.00
Market Cap
Previous Close
19.58
Open
19.53
Last Trade
13162
@
20.21
Last Trade Time
Financial Volume
$ 4,541,081
VWAP
20.1179
Average Volume (3m)
-
Shares Outstanding
42,779,030
Dividend Yield
-
PE Ratio
-7.64
Earnings Per Share (EPS)
-2.63
Revenue
14.46M
Net Profit
-112.72M

About Bicycle Therapeutics PLC

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused... Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, Gbr
Founded
1970
Bicycle Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BCYC. The last closing price for Bicycle Therapeutics was $19.58. Over the last year, Bicycle Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Bicycle Therapeutics currently has 42,779,030 shares outstanding. The market capitalization of Bicycle Therapeutics is $837.61 million. Bicycle Therapeutics has a price to earnings ratio (PE ratio) of -7.64.

BCYC Latest News

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates® demonstrate differentiation compared to antibody drug conjugates Trial-in-progress poster outlines...

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

Financing includes participation from new and existing investors Strengthens balance sheet, with pro forma cash position of approximately $1.0 billion, extending expected financial runway into...

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Multiple preclinical and clinical abstracts accepted for presentation at 2024 ASCO Annual Meeting and AACR Annual Meeting underscore breadth of Bicycle® platform technology and pipeline Continued...

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology...

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 4.785
(122.56%)
46.48M
SHOTWSafety Shot Inc
$ 0.33
(83.33%)
1.6k
QLGNQualigen Therapeutics Inc
$ 0.28
(59.64%)
244.69M
INVZWInnoviz Technologies Ltd
$ 0.2499
(51.91%)
17.79k
ZAPPZapp Electric Vehicles Group Ltd
$ 4.06
(49.26%)
50.34M
VEVVicinity Motor Corporation
$ 0.391
(-30.67%)
409.44k
SKYESkye Bioscience Inc
$ 5.495
(-26.34%)
354.28k
CLEUChina Liberal Education Holdings Ltd
$ 2.16
(-24.74%)
13.42M
JZXNJiuzi Holdings Inc
$ 2.60
(-23.53%)
57.7k
WHLRWheeler Real Estate Investment Trust Inc
$ 15.02
(-23.01%)
30.36k
MAXNMaxeon Solar Technologies Ltd
$ 0.2378
(36.98%)
520.76M
QLGNQualigen Therapeutics Inc
$ 0.28
(59.64%)
244.69M
NVDANVIDIA Corporation
$ 125.83
(-1.91%)
214.21M
TSLATesla Inc
$ 251.52
(2.08%)
154.53M
SIRISirius XM Holdings Inc
$ 3.715
(5.24%)
121.14M

Your Recent History

Delayed Upgrade Clock